106 GHP Healthcare & Pharma Awards 2023 With a headquarters in Washington DC, US, the distinguished company USMCA is the world’s leading multinational pharmaceutical technology service provider. It has offices in four countries, and a business scope that covers the USA, Europe, China, Africa, Australia, and more. It has strong R&D capabilities and extensive links with cooperative factories, and regulatory bodies to ease sales and help establish market stability for companies. USMCA’s work covers a wide range of areas, including R&D, production, regulatory affairs, and marketing/sales needs. It helps to develop pharmaceutical formulations, including research and development in products related to digestion problems, cardiovascular diseases, cancer treatments, the central nervous system, respiratory, and anti-infection medication. It has extensive reach, and boasts cooperative relationships with the US FDA, NIH, CDC, and many top universities. Some of its significant technical capabilities concern developing new molecules, orphan drugs, and first generic drugs. The US regulatory team at USMCA has obtained over 680 new drug approvals in the United States. It has also established firm links with a number of overseas pharmaceutical distributors, who can help companies to quickly develop within international markets, achieve rapid sales, and secure market occupation. It also provides solutions for the industry supply chain including raw materials, animal and plant materials, pharmaceutical excipients, and chemical materials. The company believes in long-term planning and investment, rooted in the international medical technology services. It is committed to strengthening cooperation with Chinese pharmaceutical companies, and the global pharmaceutical market. Its research and development department liaises with top international universities, scientific research institutions, and other research and development companies to help realise the rapid development of pharmaceutical product technology. It works hard to implement technology transfer between China and the United States, and help achieve seamless new product launches. It also helps product pipeline expansion, increased production capacity, and expanded market capabilities, whilst helping clients to reduce costs, shorten production time, and reduce investment risks. Currently USMCA is developing more than 100 products, including new drugs, generic drugs, injections, and complex dosage formulas. The production department prioritises meeting the needs of its clients, as at heart USMCA is a service company. It is not the owner of any of the products, it is a contract manufacturer with a strong focus on its customers and their patient needs. To do this it values open and honest communication, whilst providing manufacturing services to help achieve drug products for both human and animal consumption, of various batch sizes. Its assistance can be valuable at any stage of the drug lifecycle, including clinical trial phases, development, and commercial scale. As a turn-key contract manufacturer, its full range of services support product development, commercialisation, and post market approval. It is uniquely positioned, with state-of-the-art facilities, to be able to provide commercial capacity for a huge range of oral and sterile injectable drug products. It has manufacturing facilities located in the US, China, and India, which also include laboratory spaces, warehousing facilities with DEA and cold/frozen storage, and specifically designed aseptic facilities. These enable enhanced sterility assurance, to support commercial sterile capacity for a broad range of products. It covers delivery types including tablets, capsules, vials, lyophilization, suspensions, syringes, cartridges, and IV bags. When it comes to regulatory affairs, the pharmaceutical industry is hugely affected by policies, which are subject to change at any moment. It is essential to maintain up-to-the-minute information about regulations, to ensure compliance, and minimise waste of R&D resources. USMCA is knowledgeable about all stringent procedures that require adherence, and thus can be trusted to ensure the safety and effectiveness of any pharmaceutical products. It is necessary for companies to meet the regulatory requirements of all countries in which they operate, and USMCA can provide such assistance to SMEs, helping them to enter the international market via its own platform. USMCA’s team is results driven, and entrepreneurial in nature. That’s what makes it such a helpful partner in the world of international pharmaceuticals. It has recently been announced as the Best Pharmaceutical Technology Company 2023 in the Healthcare and Pharmaceutical Awards. This prestigious title is a fitting accolade for such a worthy recipient. Well done to USMCA. Company: USMCA Pharmaceutical Web Address: http://www.usmcapharm.com/ Contact Name: Xin Ping Best Pharmaceutical Technology Company 2023 Aug23137
RkJQdWJsaXNoZXIy MTUyMDQwMA==